2nd Quarter - Report
ALSTON & BIRD LLP for NORAMCO
Firm
Client
Income
$50,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
House and Senate Agriculture-FDA FY 2020 Appropriations legislation; FDA and USDA regulation of Cannabidiol (CBD).
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARC SCHEINESON | — |
| THEODORE SCHROEDER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.